Immunotherapy Plus Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Patients with Brain Metastases

1. Abstract
1.1. Aim: To investigate the association of stereotactic radiosur- gery (SRS) plus immunotherapy with overall survival (OS) com- pared to 3-5 fractions of stereotactic radiation therapy (SRT) plus immunotherapy in patients with brain metastases (BMs) from breast cancer, non-small cell lung cancer (NSCLC), and melano- ma.